Increased serum concentration of netrin-1 after intravitreal bevacizumab injection: is it a compensatory mechanism to counteract drug side effects?

Increased serum concentration of netrin-1 after intravitreal bevacizumab injection: is it a compensatory mechanism to counteract drug side effects?

Abstract Background To evaluate alterations in the serum concentrations of vascular endothelial growth factor (VEGF) and netrin-1 after intravitreal bevacizumab (BCZ) injection for the treatment of diabetic macular edema (DME). Methods This prospective case-control study included a total of 50 parti...

Full description

Bibliographic Details
Main Authors: Murat Okutucu, Hüseyin Fındık, Mehmet Gökhan Aslan, Medeni Arpa
Format: Article
Language:English
Published: BMC 2021-05-01
Series:BMC Ophthalmology
Subjects:
Vascular endothelial growth factor
Netrin-1
Bevacizumab
Macular edema
Diabetic retinopathy
Online Access:https://doi.org/10.1186/s12886-021-01989-1

Internet

https://doi.org/10.1186/s12886-021-01989-1

Similar Items